Response to ponatinib before hematopoietic stem cell transplantation in a child with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia

被引：10
|
作者：
Yamamoto, Masaki [1 ]
Hori, Tsukasa [1 ]
Igarashi, Keita [1 ]
Shimada, Hiroyuki [2 ]
Tsutsumi, Hiroyuki [1 ]
机构：
[1] Sapporo Med Univ, Dept Pediat, Sch Med, Sapporo, Hokkaido, Japan
[2] Keio Univ, Dept Pediat, Sch Med, Tokyo, Japan
来源：
PEDIATRICS INTERNATIONAL | 2018年 / 60卷 / 01期
关键词：
childhood; Philadelphia chromosome-positive acute lymphoblastic leukemia; ponatinib; relapse; CHRONIC MYELOID-LEUKEMIA; MUTATION;
D O I：
10.1111/ped.13437
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：85 / 87
页数：3
相关论文
共 50 条
  • [41] Philadelphia chromosome-positive acute lymphoblastic leukemia: Impact of imatinib treatment on remission induciton and allogeneic stem cell tranplantation
    Kovacsovics T.
    Maziarz R.T.
    Current Oncology Reports, 2006, 8 (5) : 343 - 351
  • [42] Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Cerchione, Claudio
    Locatelli, Franco
    Martinelli, Giovanni
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Current Treatment and Future Perspectives
    Lee, Hun J.
    Thompson, James E.
    Wang, Eunice S.
    Wetzler, Meir
    CANCER, 2011, 117 (08) : 1583 - 1594
  • [44] The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation
    Takayoshi Tachibana
    Yuho Najima
    Yu Akahoshi
    Shigeki Hirabayashi
    Kaito Harada
    Noriko Doki
    Naoyuki Uchida
    Takahiro Fukuda
    Masashi Sawa
    Masao Ogata
    Satoru Takada
    Masatsugu Tanaka
    Yoshiko Matsuhashi
    Junji Tanaka
    Makoto Onizuka
    Tatsuo Ichinohe
    Yoshiko Atsuta
    Shinichi Kako
    Annals of Hematology, 2020, 99 : 2393 - 2404
  • [45] Comparative Analysis of Flow Cytometry and RQ-PCR for the Detection of Minimal Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia after Hematopoietic Stem Cell Transplantation
    Zhao, Xiangyu
    Zhao, Xiaosu
    Chen, Huan
    Qin, Yazhen
    Xu, Lanping
    Zhang, Xiaohui
    Liu, Kaiyan
    Huang, Xiaojun
    Chang, Ying-Jun
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (09) : 1936 - 1943
  • [46] The impacts ofBCR-ABL1mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation
    Tachibana, Takayoshi
    Najima, Yuho
    Akahoshi, Yu
    Hirabayashi, Shigeki
    Harada, Kaito
    Doki, Noriko
    Uchida, Naoyuki
    Fukuda, Takahiro
    Sawa, Masashi
    Ogata, Masao
    Takada, Satoru
    Tanaka, Masatsugu
    Matsuhashi, Yoshiko
    Tanaka, Junji
    Onizuka, Makoto
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Kako, Shinichi
    ANNALS OF HEMATOLOGY, 2020, 99 (10) : 2393 - 2404
  • [47] Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison
    Ribera, Josep-Maria
    Prawitz, Thibaud
    Freitag, Andreas
    Sharma, Anuj
    Dobi, Balazs
    Rizzo, Federica
    Sabatelli, Lorenzo
    Patos, Petros
    ADVANCES IN THERAPY, 2023, 40 (07) : 3087 - 3103
  • [48] Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia
    Varda-Bloom, Nira
    Danylesko, Ivetta
    Shouval, Roni
    Eldror, Shiran
    Lev, Atar
    Davidson, Jacqueline
    Rosenthal, Esther
    Volchek, Yulia
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Shimoni, Avichai
    Somech, Raz
    Nagler, Arnon
    ONCOTARGET, 2017, 8 (01) : 418 - 429
  • [49] Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison
    Josep-Maria Ribera
    Thibaud Prawitz
    Andreas Freitag
    Anuj Sharma
    Balázs Dobi
    Federica Rizzo
    Lorenzo Sabatelli
    Petros Patos
    Advances in Therapy, 2023, 40 : 3087 - 3103
  • [50] Further Analytical, Pharmacokinetic, and Clinical Observations on Low-Dose Ponatinib in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Menna, Pierantonio
    De Grazia, Ugo
    Marchesi, Francesco
    Minotti, Giorgio
    Salvatorelli, Emanuela
    CHEMOTHERAPY, 2020, 65 (1-2) : 35 - 41
12345